Over the past 12 months, $APGE has been mentioned 7 times by 3 distinct FinTwit voices, with @adamfeuerstein (Adam Feuerstein ✡️) accounting for 5 of those mentions. The first mention appeared on 2026-01-06, and discussion of the ticker intensified in mid-June 2026 around acquisition news. The biotech sector voices dominated conversation about Apogee Therapeutics during this period.

On 2026-06-19, @alphaticaio reported that AbbVie was nearing a $10.9 billion deal to acquire Apogee, citing reporting from the Financial Times. By 2026-06-22, the acquisition had been announced, with @adamfeuerstein confirming "$ABBV buying $APGE $10.9B" via AbbVie's press release. On the same day, @investmentguru_ noted $APGE was among notable pre-market movers, posting a 54% gain alongside other stocks showing significant movement.